2370
vs
N
Nikkei 225
2370
Over the past 12 months, Medinet Co Ltd has underperformed Nikkei 225, delivering a return of -12% compared to the Nikkei 225's +72% growth.
Stocks Performance
2370 vs Nikkei 225
Performance Gap
2370 vs Nikkei 225
Performance By Year
2370 vs Nikkei 225
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Medinet Co Ltd
Glance View
MEDINET Co., Ltd. engages in cell processing business. The company is headquartered in Ota-Ku, Tokyo-To and currently employs 83 full-time employees. The company went IPO on 2003-10-08. The company operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. The company also provides comprehensive support services for immune cell therapy.
